Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Azilsartan manufacturers

5 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

5 products found

azilsartan

Tablets 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18212
The company is a specialty-focused pharmaceutical firm with a vision to become a leading Indian multinational, offering high-quality medicines globally. Established in 2011, the company quickly grew to become a significant player in the cardiovascular and anti-diabetic therapy areas, achieving a milestone of Rs 200 crore within ten years. The company's mission centers on ethical processes, employee-friendly initiatives, and a commitment to quality. Aiming to reach a turnover of 1000 crore by 2030, the company values transparency, ethical behavior, and inclusivity, fostering a culture of debate and understanding to drive growth and success.

Manufacturer usually replies in 38 days

azilsartan

Tablets 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17691
This company is a global pharmaceutical manufacturer with a focus on developing and manufacturing a wide range of high-quality injectable medicines. They provide a diverse product portfolio encompassing tablets, capsules, injectables, dry syrups, liquids, drops, creams, and inhalers. The company operates in the European Union and North America, demonstrating compliance with international quality standards. Their dedication to innovation and customer satisfaction is reflected in their in-house design department and their commitment to providing cost-effective solutions and reliable supply chains. Key therapy areas include cardiology, oncology, and infectious diseases, though other areas are also likely addressed. The company has a history of providing custom manufacturing solutions and research and development services, highlighting their expertise in the industry.

Manufacturer usually replies in 32 days

azilsartan + chlortalidone

Tablets 40 mg + 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20511

This CTD dossier owner and manufacturer has a strong commitment to improving health and well-being at every stage of life. Founded in 2002, it has grown from 400 employees to over 3,000, operating from its headquarters in Mumbai and across 329 locations nationwide. With state-of-the-art manufacturing facilities in Asia, the company produces over 170 products across acute and semi-chronic therapies. A dedicated R&D center in Pune, approved by DSIR, drives innovation in healthcare solutions. Ranked 7th in its directly covered market and 23rd overall in India, the company focuses on quality, social responsibility, employee welfare, and environmental sustainability, aiming to make a lasting impact on society and promote a healthier future.

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible